Lars Petter Waldø-Jensen • 1959 • Slependen • 16 roles

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
N NICOMAX AS	Managing Director/CEO	-	14,703,000	45 % directly
W WAMALINO GROUP AS	Managing Director/CEO	6,538,491	39,210,419	16.2 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
N NICOMAX AS	Chairman	-	14,703,000	45 % directly
E ENDOTECH INVEST AS	Chairman	-	24,729	27 % indirectly
U UTHUSSETRA 9 AS	Chairman	-	-163,964	22.5 % indirectly
D DATA-SECURE AS	Contact Person	1,907,466	-181,241	21.35 % indirectly
N NORDIC MEDICAL GROUP AS	Contact Person	-	30,854,620	16.2 % indirectly
W WAMALINO GROUP AS	Board Member	6,538,491	39,210,419	16.2 % indirectly
E ENDOTECH AS	Chairman	79,469,946	7,029,932	15.39 % indirectly
E ET INNOVASJON AS	Board Member	-	940,822	10.85 % indirectly
N NEORESQ AS	Board Member	200,000	46,542	7.93 % indirectly
M MABSEMBALLASJE AS	Board Member	13,504,197	90,000	-
N NDS SECURITY AS	Chairman	25,998,338	694,428	-
F FBS ENTREPRENØR AS	Board Member	11,425,712	-1,715,313	-

Last update: Jul 26, 2024

Related industries6

Direct relationships5

DN
Dag Nord1959
NDS SECURITY AS, UTHUSSETRA 9 AS, NEORESQ AS, ENDOTECH INVEST AS, ET INNOVASJON AS, ENDOTECH AS, MABSEMBALLASJE AS, NORDIC MEDICAL GROUP AS, WAMALINO GROUP AS
JL
Jørgen Lindberg1974
NDS SECURITY AS, ENDOTECH AS, MABSEMBALLASJE AS, NORDIC MEDICAL GROUP AS, WAMALINO GROUP AS
RM
Rune Martini1966
FBS ENTREPRENØR AS, NEORESQ AS
FG
Frode Granaas1967
ET INNOVASJON AS
BW
Britt Waldø-Jensen1963
NICOMAX AS

Shares owned by Lars Petter Waldø-Jensen

Name	Share class	Total operating income	Total equity	Share
N NICOMAX AS	Ordinære aksjer	0	14,703,000	45 % directly
E ENDOTECH INVEST AS		0	24,729	27 % indirectly
U UTHUSSETRA 9 AS		0	-163,964	22.5 % indirectly
D DATA-SECURE AS		1,907,466	-181,241	21.35 % indirectly
N NORDIC MEDICAL GROUP AS		0	30,854,620	16.2 % indirectly
W WAMALINO GROUP AS		6,538,491	39,210,419	16.2 % indirectly
E ENDOTECH AS		79,469,946	7,029,932	15.39 % indirectly
E ET INNOVASJON AS		0	940,822	10.85 % indirectly
N NEORESQ AS		200,000	46,542	7.93 % indirectly
N NIKKIMED AS		0	15,551	4.05 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025